Highlights include two head-to-head randomized clinical trials data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia -Additional studies examine.
WAYNE, Pa., April 02, 2024 Teleflex Incorporated , a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control feature on.
Men With Bothersome Urinary Symptoms Find Travel Less Enjoyable Due to Frequent Bathroom NeedsWAYNE, Pa., Sept. 12, 2023 Teleflex Incorporated , a leading global provider of medical.
Operator: Good morning, ladies and gentlemen, and welcome to the Teleflex s Second Quarter 2023 Earnings Conference Call. [Operator Instructions]. And now I will turn the call over to Mr.